HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousPrevalenceSexual BehaviorRisk FactorsDisease ProgressionSeroepidemiologic StudiesAntibodies, ViralCross-Sectional StudiesAntibodies, BacterialImmunoglobulin GChlamydophila pneumoniaeEnzyme-Linked Immunosorbent AssayChlamydophila InfectionsSerologic TestsHIV SeronegativityAge FactorsBrazilHelicobacter pyloriHelicobacter InfectionsRural PopulationCohort StudiesCase-Control StudiesAge DistributionAcquired Immunodeficiency SyndromeProspective StudiesHIV-1Hepatitis CToxocariasisAntibodies, ProtozoanLogistic ModelsOdds RatioBlood DonorsCytomegalovirus InfectionsIndiaTime FactorsPapillomavirus InfectionsUnited StatesSex FactorsIncidenceUrban PopulationRetrospective StudiesQuestionnairesToxoplasmosisHerpesvirus 2, HumanSex DistributionAIDS SerodiagnosisChinaToxocaraFollow-Up StudiesSyphilisSocioeconomic FactorsMultivariate AnalysisHepatitis BCD4 Lymphocyte CountTurkeyHomosexuality, MalePolymerase Chain ReactionPregnancyNeosporaHerpes GenitalisRisk-TakingImmunoglobulin ASexual PartnersHuman papillomavirus 16HomosexualityInfant, NewbornChlamydia InfectionsHepatitis ACytomegalovirusToxoplasmaHealth SurveysImmunoglobulin MHepatitis A Virus, HumanAnti-HIV AgentsComorbidityPopulation SurveillanceUgandaProstitutionAntibodies, HelminthZimbabweHepatitis C AntibodiesMass ScreeningViral LoadPapillomaviridaeCell CycleSmokingTreatment OutcomeBiological MarkersRural HealthSensitivity and SpecificitySeverity of Illness IndexLongitudinal Studies